The observed alterations in specific OXL pathways, particularly the COX-derived EPA-based and LOX-derived AA-based OXL, indicate that our in vivo model of endotoxemia recapitulates the rapid OXL biosynthetic response to endotoxin observed in vitro (42). The gene discussed is LOX; the disease is serum lipopolysaccharide activity.